AMRX
Price
$7.97
Change
-$0.27 (-3.28%)
Updated
Jul 18 closing price
Capitalization
1.87B
15 days until earnings call
SIGA
Price
$6.61
Change
-$0.09 (-1.34%)
Updated
Jul 18 closing price
Capitalization
608.54M
10 days until earnings call
Interact to see
Advertisement

AMRX vs SIGA

Header iconAMRX vs SIGA Comparison
Open Charts AMRX vs SIGABanner chart's image
Amneal Pharmaceuticals
Price$7.97
Change-$0.27 (-3.28%)
Volume$1.17M
Capitalization1.87B
SIGA Technologies
Price$6.61
Change-$0.09 (-1.34%)
Volume$274.15K
Capitalization608.54M
AMRX vs SIGA Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. SIGA commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and SIGA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (AMRX: $7.97 vs. SIGA: $6.61)
Brand notoriety: AMRX and SIGA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 72% vs. SIGA: 69%
Market capitalization -- AMRX: $1.87B vs. SIGA: $608.54M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. SIGA’s [@Pharmaceuticals: Other] market capitalization is $608.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileSIGA’s FA Score has 2 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, SIGA is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while SIGA’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • SIGA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than SIGA.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -4.32% price change this week, while SIGA (@Pharmaceuticals: Other) price change was -2.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was +5.79%, and the average quarterly price growth was +72.07%.

Reported Earning Dates

AMRX is expected to report earnings on Nov 07, 2025.

SIGA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than SIGA($609M). AMRX has higher P/E ratio than SIGA: AMRX (90.00) vs SIGA (9.24). SIGA YTD gains are higher at: 21.460 vs. AMRX (0.631). AMRX has higher annual earnings (EBITDA): 400M vs. SIGA (84.2M). SIGA has more cash in the bank: 150M vs. AMRX (91.5M). SIGA has less debt than AMRX: SIGA (564K) vs AMRX (2.75B). AMRX has higher revenues than SIGA: AMRX (2.39B) vs SIGA (140M).
AMRXSIGAAMRX / SIGA
Capitalization1.87B609M307%
EBITDA400M84.2M475%
Gain YTD0.63121.4603%
P/E Ratio90.009.24974%
Revenue2.39B140M1,710%
Total Cash91.5M150M61%
Total Debt2.75B564K487,766%
FUNDAMENTALS RATINGS
AMRX vs SIGA: Fundamental Ratings
AMRX
SIGA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
6486
SMR RATING
1..100
9939
PRICE GROWTH RATING
1..100
5550
P/E GROWTH RATING
1..100
2529
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for AMRX (92) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (64) in the Pharmaceuticals Major industry is in the same range as SIGA (86) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to SIGA’s over the last 12 months.

SIGA's SMR Rating (39) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (99) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew somewhat faster than AMRX’s over the last 12 months.

SIGA's Price Growth Rating (50) in the Pharmaceuticals Other industry is in the same range as AMRX (55) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's P/E Growth Rating (25) in the Pharmaceuticals Major industry is in the same range as SIGA (29) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to SIGA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXSIGA
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 5 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGARX25.650.02
+0.08%
Virtus SGA Global Growth R6
LCEIX19.050.01
+0.05%
Invesco Diversified Dividend Investor
BEMCX10.11-0.01
-0.10%
Brandes Emerging Markets Value C
AMINX69.35-0.11
-0.16%
Amana Income Institutional
JETIX16.81-0.13
-0.77%
abrdn Focused Em Markets ex-China Instl

SIGA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIGA has been loosely correlated with EBS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SIGA jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
-1.34%
EBS - SIGA
34%
Loosely correlated
-4.81%
OGI - SIGA
29%
Poorly correlated
-0.68%
CRRTF - SIGA
26%
Poorly correlated
N/A
AMRX - SIGA
25%
Poorly correlated
-3.28%
EVOK - SIGA
23%
Poorly correlated
-1.08%
More